Order Article Reprints

Erber R, Hartmann A, Fasching PA, Ruebner M, Stöhr R, Beckmann MW, Zentgraf M, Popp V, Weidler J, Simon I, et al. Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment. Cancers. 2021; 13(18):4718. https://doi.org/10.3390/cancers13184718

Erber, Ramona, Arndt Hartmann, Peter Andreas Fasching, Matthias Ruebner, Robert Stöhr, Matthias Wilhelm Beckmann, Miriam Zentgraf, Verena Popp, Jodi Weidler, Iris Simon, and et al. 2021. "Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment" Cancers 13, no. 18: 4718. https://doi.org/10.3390/cancers13184718

Erber, R., Hartmann, A., Fasching, P. A., Ruebner, M., Stöhr, R., Beckmann, M. W., Zentgraf, M., Popp, V., Weidler, J., Simon, I., Becker, S., Huebner, H., Fischer, J., Guerini Rocco, E., Viale, G., Cayre, A., Penault-Llorca, F., Caniego Casas, T., Pérez-Miés, B., ... Ferrazzi, F. (2021). Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment. Cancers, 13(18), 4718. https://doi.org/10.3390/cancers13184718